Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METHOD OF PRODUCING LYMPHOCYTES
Document Type and Number:
WIPO Patent Application WO/2007/020880
Kind Code:
A1
Abstract:
A method of producing lymphocytes characterized by comprising the step of performing enlarged culture in the presence of (a) fibronectin, its fragment or a mixture thereof, (b) CD3 ligand and (c) CD28 ligand.

Inventors:
MARUI TAKAHIRO
NAGAMINE KINUKO
MURAKI NOBUKO
KATO AKIKO
ENOKI TATSUJI
SAGAWA HIROAKI
KATO IKUNOSHIN
Application Number:
PCT/JP2006/315881
Publication Date:
February 22, 2007
Filing Date:
August 10, 2006
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TAKARA BIO INC (JP)
MARUI TAKAHIRO
NAGAMINE KINUKO
MURAKI NOBUKO
KATO AKIKO
ENOKI TATSUJI
SAGAWA HIROAKI
KATO IKUNOSHIN
International Classes:
C12N15/12; A61K35/14; A61K35/17; A61K35/26; A61K35/76; A61K35/761; A61P35/00; A61P37/04; C07K14/78; C07K16/28; C07K17/14; C12M3/00; C12N5/07; C12N5/078; C12N5/0783; C12N5/10; C12N15/09; C12N15/113; C07K14/435
Domestic Patent References:
WO2005019450A12005-03-03
WO2001062895A22001-08-30
WO2003016511A12003-02-27
WO2003080817A12003-10-02
WO1996006929A21996-03-07
WO1997032970A11997-09-12
WO2003016511A12003-02-27
WO2003080817A12003-10-02
WO2005019450A12005-03-03
WO1997018318A11997-05-22
WO2000009168A12000-02-24
WO2002014481A12002-02-21
Foreign References:
JPH0380076A1991-04-04
US5198423A1993-03-30
US5102988A1992-04-07
JP3104178B22000-10-30
JP2729712B21998-03-18
Other References:
HIBINO S. ET AL.: "Tenascin suppresses CD3-mediated T cell activation", BIOCHEM. BIOPHYS. RES. COMMUN., vol. 250, 1998, pages 119 - 124, XP003002657
HALVORSON M.J. ET AL.: "alpha4 and alpha5 integrins costimulate the CD3-dependent proliferation of fetal thymocytes", CELL IMMUNOL., vol. 189, 1998, pages 1 - 9, XP003002658
GREENBERG, P. D., ADVANCES IN IMMUNOLOGY, 1992
REUSSER P., BLOOD, vol. 78, no. 5, 1991, pages 1373 - 1380
RIDDELL S. A., J. IMMUNOL., vol. 146, no. 8, 1991, pages 2795 - 2804
GREENBERG, P.D., J. IMMUNOL. METHODS, vol. 128, no. 2, 1990, pages 189 - 201
ROSENBERG S. A. ET AL., N. ENGL. J. MED., vol. 316, no. 15, 1987, pages 889 - 897
ROSENBERG S. A. ET AL., N. ENGL. J. MED., vol. 319, no. 25, 1988, pages 1676 - 1680
HO M., BLOOD, vol. 81, no. 8, 1993, pages 2093 - 2101
KOBERDA J., J. CANCER RES. CLIN. ONCOL., vol. 119, no. 3, 1993, pages 131 - 136
DEANE F. MOMER: "FIBRONECTIN", 1988, ACADEMIC PRESS INC., pages: 1 - 8
KIMIZUKA F., J. BIOCHEM., vol. 110, no. 2, 1991, pages 284 - 291
HANENBERG H., HUMAN GENE THERAPY, vol. 8, no. 18, 1997, pages 2193 - 2206
RUOSLAHTI E. ET AL., J. BIOL. CHEM., vol. 256, no. 14, 1981, pages 7277 - 7281
KIMIDUKA F. ET AL., J. BIOCHEM., vol. 110, 1991, pages 284 - 291
KORNBRIHTT A. R. ET AL., EMBO J., vol. 4, no. 7, 1985, pages 1755 - 1759
SEKIGUCHI K. ET AL., BIOCHEMISTRY, vol. 25, no. 17, 1986, pages 4936 - 4941
WILLIAMS D. A. ET AL., NATURE, vol. 352, 1991, pages 438 - 441
SAIBO KOGAKU, CELL TECHNOLOGY, vol. 14, no. 2, 1995, pages 223 - 227
SAIBO BAIYO, CELL CULTURE, vol. 17, no. 6, 1991, pages 192 - 195
THE LANCET, vol. 356, 2000, pages 802 - 807
ZHOU X.Y. ET AL., THE JOUNAL OF IMMUNOLOGY, vol. 168, 2002, pages 3847 - 3854
See also references of EP 1916302A4
Attorney, Agent or Firm:
HOSODA, Yoshinori (P.O. Box 26 OMM Building 5th Floor, 7-31, Otemae 1-chome, Chuo-k, Osaka-shi Osaka 91, JP)
Download PDF: